Alvine Pharmaceuticals Garners $6,006,000 New Round

  • Feed Type
  • Date
    1/3/2013
  • Company Name
    Alvine Pharmaceuticals
  • Mailing Address
    75 Shoreway Rd San Carlos, CA 94070
  • Company Description
    Alvine Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutics for the treatment of Celiac sprue.
  • Website
    http://www.alvinepharma.com
  • Transaction Type
    Debt
  • Transaction Amount
    $6,006,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.